Impact of antifibrotic therapy on mortality and acute exacerbation in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
Background Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung
disease associated with significant morbidity and mortality. Nintedanib and pirfenidone are …
disease associated with significant morbidity and mortality. Nintedanib and pirfenidone are …
Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
T Petnak, P Lertjitbanjong, C Thongprayoon… - …, 2021 - mahidol.elsevierpure.com
Background: Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung
disease associated with significant morbidity and mortality. Nintedanib and pirfenidone are …
disease associated with significant morbidity and mortality. Nintedanib and pirfenidone are …
Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
T Petnak, P Lertjitbanjong, C Thongprayoon, T Moua - CHEST, 2021 - journal.chestnet.org
Background Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung
disease associated with significant morbidity and mortality. Nintedanib and pirfenidone are …
disease associated with significant morbidity and mortality. Nintedanib and pirfenidone are …
Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
T Petnak, P Lertjitbanjong, C Thongprayoon… - …, 2021 - mayoclinic.elsevierpure.com
Background: Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung
disease associated with significant morbidity and mortality. Nintedanib and pirfenidone are …
disease associated with significant morbidity and mortality. Nintedanib and pirfenidone are …
[引用][C] Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis
T Petnak, P Lertjitbanjong, C Thongprayoon, T Moua - Chest, 2021 - cir.nii.ac.jp
Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary
Fibrosis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Fibrosis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.
T Petnak, P Lertjitbanjong, C Thongprayoon, T Moua - Chest, 2021 - europepmc.org
Background Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung
disease associated with significant morbidity and mortality. Nintedanib and pirfenidone are …
disease associated with significant morbidity and mortality. Nintedanib and pirfenidone are …
Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
T Petnak, P Lertjitbanjong, C Thongprayoon… - Chest, 2021 - pubmed.ncbi.nlm.nih.gov
Background Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung
disease associated with significant morbidity and mortality. Nintedanib and pirfenidone are …
disease associated with significant morbidity and mortality. Nintedanib and pirfenidone are …